• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.85% Nasdaq Up0.74%

    More On NVSN.MX



    News & Info


    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Novartis AG (NVSN.MX)

    1,562.63 Up 13.97(0.90%) Oct 6
    ProfileGet Profile for:
    Novartis AG
    Lichtstrasse 35
    Basel, 4056
    Switzerland - Map
    Phone: 41 61 324 11 11
    Website: http://www.novartis.com

    Index Membership:N/A
    Industry:Drug Manufacturers - Major
    Full Time Employees:120,000

    Business Summary 

    Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide. Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, such as oncology, cardio-metabolic, immunology and dermatology, retina, respiratory, neuroscience, and established medicines. The company’s Alcon division provides various eye care products, including surgical, ophthalmic pharmaceuticals, and vision care products; ophthalmic surgical equipment, instruments, disposable products, and intraocular lenses; medicines to treat chronic and acute diseases of the eye; over-the-counter medicines for the eye; and contact lenses and lens care products. Its Sandoz division offers generic pharmaceuticals comprising active ingredients and finished dosage forms of pharmaceuticals; active pharmaceutical ingredients and intermediates primarily antibiotics; protein or biotechnology-based products; and cytotoxic products for the hospital market, as well as biotech manufacturing services to other companies. The company distributes its OTC products through various channels, such as pharmacies, food, drug, and mass retail outlets. Novartis AG has collaboration with Amgen Inc. in the areas of Alzheimer's disease and migraine. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Novartis AG

    Key Executives 
    Mr. Joseph Jimenez Jr., MBA, 55
    Chief Exec. Officer
    Mr. Harry Kirsch , 49
    Chief Financial Officer
    Dr. Felix R. Ehrat Ph.D., 58
    Gen. Counsel and Gen. Counsel of Novartis International Ag
    Mr. Steven Baert , 40
    Head of HR
    Dr. Jürgen Brokatzky-Geiger Ph.D., 63
    Global Head of Corp. Responsibility
    Mr. David R. Epstein B.Sc., M.B.A., 53
    Division Head of Novartis Pharmaceuticals
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in MXN.